Crinetics Pharmaceuticals CRNX Convertible Preferred Stock Outstanding Shares
Convertible Preferred Stock Outstanding Shares at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Questions, answered.
- What is Crinetics Pharmaceuticals's convertible preferred stock outstanding shares?
- Crinetics Pharmaceuticals (CRNX) reported convertible preferred stock outstanding shares of 0 in Q1 2026.